Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.47 BRL | +3.28% | +2.99% | -19.79% |
May. 10 | Fleury Seeks Acquisitions | CI |
May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.79% | 1.49B | A- | ||
-22.94% | 7.77B | B+ | ||
+75.45% | 4.51B | C+ | ||
+6.87% | 2.76B | B- | ||
-2.28% | 2.67B | - | ||
-47.96% | 2.09B | B- | ||
-17.18% | 1.72B | C- | ||
+18.29% | 1.22B | B+ | ||
-44.77% | 1.12B | C+ | ||
+20.68% | 1.05B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FLRY3 Stock
- Ratings Fleury S.A.